Literature DB >> 9449662

Retinal axon guidance by region-specific cues in diencephalon.

R Tuttle1, J E Braisted, L J Richards, D D O'Leary.   

Abstract

Retinal axons show region-specific patterning along the dorsal-ventral axis of diencephalon: retinal axons grow in a compact bundle over hypothalamus, dramatically splay out over thalamus, and circumvent epithalamus as they continue toward the dorsal midbrain. In vitro, retinal axons are repulsed by substrate-bound and soluble activities in hypothalamus and epithalamus, but invade thalamus. The repulsion is mimicked by a soluble floor plate activity. Tenascin and neurocan, extracellular matrix molecules that inhibit retinal axon growth in vitro, are enriched in hypothalamus and epithalamus. Within thalamus, a stimulatory activity is specifically upregulated in target nuclei at the time that retinal axons invade them. These findings suggest that region-specific, axon repulsive and stimulatory activities control retinal axon patterning in the embryonic diencephalon.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449662     DOI: 10.1242/dev.125.5.791

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  12 in total

1.  Neurocan is upregulated in injured brain and in cytokine-treated astrocytes.

Authors:  R A Asher; D A Morgenstern; P S Fidler; K H Adcock; A Oohira; J E Braistead; J M Levine; R U Margolis; J H Rogers; J W Fawcett
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

2.  Roles of the telencephalic cells and their chondroitin sulfate proteoglycans in delimiting an anterior border of the retinal pathway.

Authors:  H Ichijo; I Kawabata
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  Differential gene expression in the developing lateral geniculate nucleus and medial geniculate nucleus reveals novel roles for Zic4 and Foxp2 in visual and auditory pathway development.

Authors:  Sam Horng; Gabriel Kreiman; Charlene Ellsworth; Damon Page; Marissa Blank; Kathleen Millen; Mriganka Sur
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

4.  Randomized retinal ganglion cell axon routing at the optic chiasm of GAP-43-deficient mice: association with midline recrossing and lack of normal ipsilateral axon turning.

Authors:  D W Sretavan; K Kruger
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

5.  Entorhinal cortex lesion in adult rats induces the expression of the neuronal chondroitin sulfate proteoglycan neurocan in reactive astrocytes.

Authors:  C A Haas; U Rauch; N Thon; T Merten; T Deller
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

6.  Chemoattraction and chemorepulsion of olfactory bulb axons by different secreted semaphorins.

Authors:  F de Castro; L Hu; H Drabkin; C Sotelo; A Chédotal
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

7.  Slit inhibition of retinal axon growth and its role in retinal axon pathfinding and innervation patterns in the diencephalon.

Authors:  T Ringstedt; J E Braisted; K Brose; T Kidd; C Goodman; M Tessier-Lavigne; D D O'Leary
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

8.  Slit2 is a repellent for retinal ganglion cell axons.

Authors:  S P Niclou; L Jia; J A Raper
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

9.  Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain.

Authors:  Li Hong Shen; Yi Li; Qi Gao; Smita Savant-Bhonsale; Michael Chopp
Journal:  Glia       Date:  2008-12       Impact factor: 7.452

10.  Foxg1 regulates retinal axon pathfinding by repressing an ipsilateral program in nasal retina and by causing optic chiasm cells to exert a net axonal growth-promoting activity.

Authors:  Natasha M Tian; Thomas Pratt; David J Price
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.